European Archives of Oto-Rhino-Laryngology

, Volume 269, Issue 12, pp 2461–2465

Inflammatory myofibroblastic tumors of the head and neck: evaluation of clinicopathologic and prognostic features


  • Kenneth O. Devaney
    • Department of PathologyAllegiance Health
  • Daniel J. LaFeir
    • Department of PathologyAllegiance Health
  • Asterios Triantafyllou
    • Oral Pathology, School of Dental Sciences and Dental HospitalUniversity of Liverpool
  • William M. Mendenhall
    • Department of Radiation OncologyUniversity of Florida
  • Julia A. Woolgar
    • Oral Pathology, School of Dental Sciences and Dental HospitalUniversity of Liverpool
  • Alessandra Rinaldo
    • ENT ClinicUniversity of Udine
    • ENT ClinicUniversity of Udine
Review Article

DOI: 10.1007/s00405-012-2026-3

Cite this article as:
Devaney, K.O., LaFeir, D.J., Triantafyllou, A. et al. Eur Arch Otorhinolaryngol (2012) 269: 2461. doi:10.1007/s00405-012-2026-3


Head and neck lesions composed of spindle cells evoke a differential diagnosis which includes a host of benign and malignant entities. One of the less common spindle cell lesions in this region is the inflammatory myofibroblastic tumor (IMT). Although IMTs were originally regarded as “pseudotumors”, they are now recognized to be true neoplasms. Local recurrence, and, rarely, malignant change have been reported. Currently, the definitive means of diagnosing IMTs is the identification of a rearrangement of the anaplastic lymphoma kinase gene (at chromosome 2p23) by fluorescence in situ hybridization. The histopathologic differential diagnosis includes infectious processes, other fibro-inflammatory lesions, lymphoma, the inflammatory variant of malignant fibrous histiocytoma, and sarcomatoid (spindle cell) carcinoma. Complete surgical excision is the treatment of choice.


Inflammatory myofibroblastic tumorInflammatory pseudotumorPseudosarcomatous myofibroblastic proliferationPlasma cell granuloma

Copyright information

© Springer-Verlag 2012